The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF) (ESPFA-CN21)
The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)-A Prospective Multicenter Single-arm Study
Sponsor: Central South University
A NA clinical study on Paroxysmal Atrial Fibrillation, this trial is ongoing. The trial is conducted by Central South University and has accumulated 7 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Jan 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Jan 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Sep 2023 — Jun 2024 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Feb 2023 — Sep 2023 [monthly]
Recruiting NA
-
Jul 2022 — Feb 2023 [monthly]
Recruiting NA
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central South University
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Jiangxi Provincial People's Hopital
- Second Affiliated Hospital of Guangzhou Medical University
- Second Affiliated Hospital of Nanchang University
- The First Affiliated Hospital of Dalian Medical University
- Tongji Hospital
- Zhongshan Hospital Xiamen University
For direct contact, visit the study record on ClinicalTrials.gov .